Article

Relevance of Pharmacogenetic Polymorphisms With Response to Docetaxel, Cisplatin, and 5-Fluorouracil Chemotherapy in Esophageal Cancer.

2021-10-19

Abstract excerpt

<title>Abstract</title> <p><bold>Purpose: </bold>Docetaxel, cisplatin, and 5-fluorouracil (DCF) have high response rates, but severe neutropenia is frequently observed. The occurrence of neutropenia is associated with high histological response in solid tumors, and it might be associated with tumor shrinkage after DCF therapy. This study aimed to determine the genetic polymorphisms involved in the clinical respon...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b128a869-008e-5ea9-b5b4-4f78dcb687a6
DOI: 10.21203/rs.3.rs-967707/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Relevance of Pharmacogenetic Polymorphisms With Response to Docetaxel, Cisplatin, and 5-Fluorouracil Chemotherapy in Esophageal Cancer.DOI 10.21203/rs.3.rs-967707/v1Read

NEF2L2 rs35652124C>T Polymorphism Predicts Grade 4 Neutropenia in Esophageal Cancer Patients Treated with Docetaxel, Cisplatin, and Fluorouracil Chemotherapy: Results from Exploratory and Validation CohortsSemantic proximity Read

ABCB1 and ABCC2 genetic polymorphism as risk factors for neutropenia in esophageal cancer patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy.Semantic proximity Read

Pharmacokinetics and pharmacogenomics in esophageal cancer chemoradiotherapy.Semantic proximity Read

NFE2L2 rs35652124C>T polymorphism predicts Grade 4 neutropenia in esophageal cancer patients treated with docetaxel, cisplatin, and fluorouracil chemotherapy: results from exploratory and validation cohorts.Semantic proximity Read

Phase 1a/1b and pharmacogenetic study of docetaxel, oxaliplatin and capecitabine in patients with advanced cancer of the stomach or the gastroesophageal junction.Semantic proximity Read

Use of germline polymorphisms in predicting concurrent chemoradiotherapy response in esophageal cancer.Semantic proximity Read

Different response rates to chemotherapy between Japanese and German esophageal squamous cell carcinoma: patients may be influenced by ERCC1 or ABCB1.Semantic proximity Read

Esophageal cancer: Risk factors, genetic association, and treatment.Semantic proximity Read

ERCC1 single nucleotide polymorphism C8092A, but not its expression is associated with survival of esophageal squamous cell carcinoma patients from Fujian province, China.Semantic proximity Read

Cisplatin plus weekly CPT-11/docetaxel in advanced esophagogastric cancer: a phase I study with pharmacogenetic assessment of XPD, XRCC3 and UGT1A1 polymorphisms.Semantic proximity Read

Development of a machine-learning model for therapeutic efficacy prediction of preoperative treatment for esophageal cancer using single nucleotide variants of autophagy-related genesSemantic proximity Read

A germline predictive signature of response to platinum chemotherapy in esophageal cancer.Semantic proximity Read